Valid for Submission
D64.3 is a billable diagnosis code used to specify a medical diagnosis of other sideroblastic anemias. The code D64.3 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code D64.3 might also be used to specify conditions or terms like autosomal-linked pyridoxine refractory sideroblastic anemia, idiopathic sideroblastic anemia, pyridoxine-responsive sideroblastic anemia, secondary acquired sideroblastic anemia, sideroblastic anemia , x chromosome-linked pyridoxine responsive sideroblastic anemia, etc.
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code D64.3:
Inclusion TermsInclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Sideroblastic anemia NOS
- Pyridoxine-responsive sideroblastic anemia NEC
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D64.3 are found in the index:
- - Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) - D64.9
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Autosomal-linked pyridoxine refractory sideroblastic anemia
- Idiopathic sideroblastic anemia
- Pyridoxine-responsive sideroblastic anemia
- Secondary acquired sideroblastic anemia
- Sideroblastic anemia
- X chromosome-linked pyridoxine responsive sideroblastic anemia
- X chromosome-linked sideroblastic anemia
- ANEMIA SIDEROBLASTIC-. anemia characterized by the presence of erythroblasts containing excessive deposits of iron in the marrow.
Diagnostic Related Groups - MS-DRG Mapping
|MS-DRG||MS-DRG Title||MCD||Relative Weight|
|811||RED BLOOD CELL DISORDERS WITH MCC||16||1.3776|
|812||RED BLOOD CELL DISORDERS WITHOUT MCC||16||0.8797|
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Convert D64.3 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code D64.3 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
Information for Patients
If you have anemia, your blood does not carry enough oxygen to the rest of your body. The most common cause of anemia is not having enough iron. Your body needs iron to make hemoglobin. Hemoglobin is an iron-rich protein that gives the red color to blood. It carries oxygen from the lungs to the rest of the body.
Anemia has three main causes: blood loss, lack of red blood cell production, and high rates of red blood cell destruction.
Conditions that may lead to anemia include
- Heavy periods
- Colon polyps or colon cancer
- Inherited disorders
- A diet that does not have enough iron, folic acid or vitamin B12
- Blood disorders such as sickle cell anemia and thalassemia, or cancer
- Aplastic anemia, a condition that can be inherited or acquired
- G6PD deficiency, a metabolic disorder
Anemia can make you feel tired, cold, dizzy, and irritable. You may be short of breath or have a headache.
Your doctor will diagnose anemia with a physical exam and blood tests. Treatment depends on the kind of anemia you have.
NIH: National Heart, Lung, and Blood Institute
[Learn More in MedlinePlus]